Vasundhara Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.23 M
as on 16-11-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -74.96%
(FY 2023)
- Profit -95.97%
(FY 2023)
- Ebitda -80.46%
(FY 2023)
- Net Worth 0.15%
(FY 2023)
- Total Assets -0.44%
(FY 2023)
About Vasundhara Bio Sciences
The Corporate was formerly known as Vasundhara Bio Electricity Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.23 M, as per Ministry of Corporate Affairs (MCA) records.
Lalit Singhania, Mohanlal Singhania, Ajit Varma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U40107CT2005PTC017309
- Company No.
017309
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vasundhara Bio Sciences?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lalit Singhania | Director | 07-Feb-2005 | Current |
Harshit Singhania | Director | 25-Oct-2016 | Current |
Mohanlal Singhania | Director | 07-Feb-2005 | Current |
Ajit Varma | Director | 18-Apr-2018 | Current |
Vatsala Agarwal | Director | 25-Oct-2016 | Current |
Financial Performance and Corporate Structure Insights of Vasundhara Bio Sciences.
Vasundhara Bio Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.96% decrease. The company also saw a substantial fall in profitability, with a 95.97% decrease in profit. The company's net worth moved up by a moderate rise of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vasundhara Bio Sciences?
In 2023, Vasundhara Bio Sciences had a promoter holding of 35.26% and a public holding of 64.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aditya Geowealth Impex Private LimitedActive 37 years 11 months
Lalit Singhania and Mohanlal Singhania are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vasundhara Bio Sciences?
Unlock and access historical data on people associated with Vasundhara Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vasundhara Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vasundhara Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.